Pharsight

Drugs that contain Naproxen Sodium; Sumatriptan Succinate

1. Treximet patents expiration

TREXIMET Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6586458 CURRAX Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
Aug, 2017

(6 years ago)

US8022095 CURRAX Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
Aug, 2017

(6 years ago)

US5872145 CURRAX Formulation of 5-HT agonist and NSAID for treatment of migraine
Aug, 2017

(6 years ago)

US6060499 CURRAX Anti-migraine methods and compositions using 5-HT agonists with long-acting NSAIDs
Aug, 2017

(6 years ago)

US6586458

(Pediatric)

CURRAX Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
Feb, 2018

(6 years ago)

US8022095

(Pediatric)

CURRAX Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
Feb, 2018

(6 years ago)

US6060499

(Pediatric)

CURRAX Anti-migraine methods and compositions using 5-HT agonists with long-acting NSAIDs
Feb, 2018

(6 years ago)

US5872145

(Pediatric)

CURRAX Formulation of 5-HT agonist and NSAID for treatment of migraine
Feb, 2018

(6 years ago)

US7332183 CURRAX Multilayer dosage forms containing NSAIDs and triptans
Oct, 2025

(1 year, 5 months from now)

US7332183

(Pediatric)

CURRAX Multilayer dosage forms containing NSAIDs and triptans
Apr, 2026

(1 year, 11 months from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) May 14, 2018
Pediatric Exclusivity(PED) Nov 14, 2018

Market Authorisation Date: 14 May, 2015

Treatment: Acute treatment of migraine; Treatment of migraine

Dosage: TABLET;ORAL

How can I launch a generic of TREXIMET before it's drug patent expiration?
More Information on Dosage

TREXIMET family patents

Family Patents